Inovio To Begin Rolling Submission Of BLA For Ino-3107 For The Treatment Of RRP In Adults

Inovio Pharmaceuticals Inc INO:

• INOVIO TO BEGIN ROLLING SUBMISSION OF BLA FOR INO-3107 FOR THE TREATMENT OF RRP IN ADULTS

• INOVIO PHARMACEUTICALS INC - BLA SUBMISSION ON TRACK FOR 2H25, FDA ACCEPTANCE BY END 2025